IMU Biosciences
Profiles the human immune system at scale using multi-omic analysis and machine learning to transform disease diagnosis and treatment
$53MSeries A
Role not disclosedLoading investors…
Activity from announced rounds
Profiles the human immune system at scale using multi-omic analysis and machine learning to transform disease diagnosis and treatment